SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-23-011052
Filing Date
2023-03-10
Accepted
2023-03-10 09:30:48
Documents
1
Effectiveness Date
2023-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 POS brhc10049387_s8pos.htm S-8 POS 20712
  Complete submission text file 0001140361-23-011052.txt   21757
Mailing Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB
Business Address SUITE 1, 3RD FLOOR 11-12 ST. JAMES SQUARE LONDON X0 SW1Y 4LB 44 207-400-3351
Myovant Sciences Ltd. (Filer) CIK: 0001679082 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 0331
Type: S-8 POS | Act: 33 | File No.: 333-228277 | Film No.: 23721877
SIC: 2834 Pharmaceutical Preparations